Project Grant F32AI178963
Award Date
11/14/24
Completion Date
5/31/26
Dollars Obligated
$154K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Washington, USA
Similar Awards
This Project Grant award for $2,960,775.00, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research on mechanisms that compromise CD8 T cell responses to malaria vaccination in individuals with prior malaria exposure. The primary goal is to gain mechanistic insight into how hemozoin, a byproduct of malaria infection, disrupts antigen presentation and impairs CD8 T cell priming and...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $244,440.00 to Albert Einstein College of Medicine to investigate the role of cytolytic memory CD4+ T cells in protection against malaria. The research aims to use murine models to explore the kinetics, differentiation requirements, functions, and protective capacity of circumsporozoite protein (CSP)-specific...
This federal Project Grant award, totaling $1,163,599.00 and issued by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), funds research to enhance T and B cell responses to Plasmodium infection and vaccination using IL-15 therapy. The primary award recipient is the Hennepin Healthcare Research Institute (HHRI), a non-profit research organization in Minneapolis, MN. HHRI will utilize novel mouse models and...
This $1,845,103 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to define the immunogenic landscape of early mosquito-stage Plasmodium falciparum parasites. The goal is to accelerate the discovery of malaria transmission-blocking vaccines. The research involves using mass spectrometry-based proteomics to comprehensively catalog surface-exposed proteins in P. falciparum...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $813,160 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to George Washington University to develop mRNA-LNP vaccines targeting multiple stages and species of the human malaria parasite. The funding will support research to evaluate the protective efficacy of individual and combination vaccine antigens from Plasmodium falciparum and Plasmodium vivax, the two main malaria parasite species...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $479,204 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Maryland, Baltimore. The 2-year award, effective from July 2024 through May 2026, will support research to identify parasite variant surface antigens associated with severe malaria in Zambian children and adults. The project aims to sequence variant surface antigen transcripts from severe malaria cases and...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $783,961 to The Johns Hopkins University to investigate the mechanisms underlying mosquito infectiousness in malaria. The key objectives are to determine the inocula associated with low- and high-infected mosquitoes using both rodent and human malaria parasites, as well as compare the quality of sporozoites...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Harvard College President & Fellows Of, through its Harvard T.H. Chan School of Public Health Division. The $889,749 grant, awarded on May 16, 2024, will fund research to globally identify the Plasmodium falciparum invasion ligand bindome, which is a critical gap in understanding the malaria parasite's invasion process. The...
This federal Project Grant award in the amount of $520,809, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research aimed at understanding the role of TAM receptors in modulating the humoral immune response against parasitic infections, particularly malaria. The overarching goal of this 5-year research program is to identify molecular and cellular immune mechanisms that contribute to...
This $845,600 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to understand the molecular mechanisms governing the formation of dormant liver stage parasites (hypnozoites) in Plasmodium vivax malaria. The awardee, the University of Georgia Research Foundation, Inc., will characterize different strains of P. vivax sporozoites to determine if their fate to...